biote Corp. (BTMDW) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $1.61. It has a SharesGrow Score of 78/100, indicating a strong investment profile with 4 out of 7 criteria passed.
Financials: revenue is $192M, +5.4%/yr average growth. Net income is $27M, growing at +300.8%/yr. Net profit margin is 14.1% (healthy). Gross margin is 71.5% (+4.6 pp trend).
Balance sheet: total debt is $110M with negative equity of -$59M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 1.22 (adequate). Debt-to-assets is 102.1%. Total assets: $108M.
Analyst outlook: 2 / 2 analysts rate BTMDW as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 83/100 (Pass), Past 100/100 (Pass), Health 50/100 (Partial), Moat 58/100 (Partial), Future 100/100 (Pass), Income 55/100 (Partial).
